“Designing of heterocyclic compounds as promising VEGFR2 tyrosine kinase inhibitors: An Insilico analysis” (2021) International Journal of Pharmaceutical Sciences and Drug Research, 13(6), pp. 685–698. doi:10.25004/IJPSDR.2021.130612.